2m 2m 2m 2m 2m 2m 2m
TG Therap (TGTX)
NASDAQ
$54.65-$0.36 (-0.65%)
Price as of Jul 13, 2026 7:51 PM EDT- $8.7BMarket Cap
- 41.34%1-Year Change
- BiotechnologyIndustry
TG Therap (TGTX)
$54.65-$0.36 (-0.65%)
TGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $55.01 | ||
Change | -$2.11 (-3.69%) | ||
Open | $56.60 | ||
High | $56.92 | ||
Low | $54.00 | ||
Previous Close | $57.12 | ||
Volume | 1,950,898 | ||
30-Day Average Volume | 2,939,945 | ||
1-Week Change | -0.83% | ||
1-Month Change | 11.09% | ||
1-Year Change | 41.34% | ||
3-Year Change | 152.92% | ||
5-Year Change | 42.14% | ||
Fundamentals | |||
Shares Outstanding | 153.1M | ||
Total Assets | $1.5B | ||
Market Cap | $8.7B | ||
Enterprise Value | $9.0B | ||
Period: QTR TTM FY | |||
Revenue | $201.3M | ||
Net Income | $19.8M | ||
Free Cash Flow | -$17.9M | ||
EBIT | $20.4M | ||
EBITDA | $20.4M | ||
Net Working Capital | $899.9M | ||
EPS | $0.12 | ||
Enterprise Value/EBITDA | 444 | ||
Enterprise Value/Revenue | 45 | ||
P/B | 15 | ||
P/E | 476 | ||
PEG | -28 | ||
Price/Free Cash Flow | -487 | ||
Price/Operating Cash Flow | -489 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 56.25 | ||
Last Split Date | 04/30/2012 | ||
Earnings & Revenue